Kristin Stafford
Vermogen: 365 797 $ op 30-09-2026
Vermogen: 365 797 $ op 30-09-2026
Ms. Kristin Stafford, CPA, is a Chief Financial Officer & Executive Vice President at Zymeworks, Inc., an Independent Director at NovoCure Ltd. and a Chief Accounting Officer & Senior Vice President at Royalty Pharma Plc.
She is on the Board of Directors at Theravance Biopharma, Inc. and NovoCure Ltd. Ms. Stafford was previously employed as a Chief Financial Officer by BioPharma Credit PLC, a Director-Capital Markets by Ernst & Young LLP (United Kingdom), and an Auditor by Deloitte & Touche LLP.
She received her undergraduate degree from Sonoma State University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
NOVOCURE LTD. 0,02% | 03-06-2026 | 22.934 ( 0,02% ) | 365 797 $ | 30-09-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ROYALTY PHARMA PLC | Comptroller/Controller/Auditor | 01-12-2018 |
| NOVOCURE LIMITED | Directeur/Bestuurslid | 28-03-2023 |
| ZYMEWORKS INC. | Financieel Directeur/CFO | 01-04-2026 |
| THERAVANCE BIOPHARMA | Directeur/Bestuurslid | 23-09-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOPHARMA CREDIT PLC | Financieel Directeur/CFO | 01-01-2018 |
Ernst & Young LLP (United Kingdom)
Ernst & Young LLP (United Kingdom) Miscellaneous Commercial ServicesCommercial Services Provides assurance, tax consulting, strategy, transactions and risk advisory services | Corporate Officer/Principal | 01-12-2016 |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Comptroller/Controller/Auditor | 01-05-2008 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 8 |
|---|---|
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
Sonoma State University
Sonoma State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ernst & Young LLP (United Kingdom)
Ernst & Young LLP (United Kingdom) Miscellaneous Commercial ServicesCommercial Services Provides assurance, tax consulting, strategy, transactions and risk advisory services | Commercial Services |
NovoCure Ltd.
NovoCure Ltd. Medical SpecialtiesHealth Technology Operates as a commercial-stage oncology company | Health Technology |
Theravance Biopharma, Inc.
Theravance Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of human therapeutics products for respiratory diseases | Health Technology |
BioPharma Credit PLC
BioPharma Credit PLC Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
Royalty Pharma Plc
Royalty Pharma Plc Pharmaceuticals: MajorHealth Technology Buys and operates a portfolio of biopharmaceutical royalties | Health Technology |
Zymeworks, Inc.
Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau